What You Should Know:
- Proscia, a Philadelphia-based provider of digital and computational pathology solutions raises $37M to advance the way we understand and treat diseases like cancer. The round includes participation from Highline Capital Management, Triangle Peak Partners, and Alpha Intelligence Capital as well as existing investors including Scale Venture Partners, Hitachi Ventures, ROBO Global, Emerald Development Managers, and Razor's Edge Ventures. This investment brings Proscia's
Read More
Proscia
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Proscia and Siemens Healthineers Expands Global Reach of Digital Pathology
What You Should Know:
- Proscia®, a digital and computational pathology solution announced a multi-year OEM agreement with Siemens Healthineers.
- Under the agreement, Siemens Healthineers will enter the market by combining its Syngo Carbon enterprise imaging solution with Proscia’s Concentriq Dx digital pathology platform.
Read More
Proscia & Hamamatsu Partner to Accelerate Scaled Adoption of Digital Pathology
What You Should Know:
- Proscia, the leader in digital and computational pathology solutions, and Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, today announced a collaboration to accelerate digital pathology adoption at an enterprise scale.
- The cooperation agreement increases the availability of the companies' best-of-breed, unified solution that combines Proscia's Concentriq® platform and Hamamatsu's NanoZoomer® series of whole slide scanners to deliver
Read More
Proscia Secures $23M for AI-Enabled Digital Pathology Solutions
What You Should Know:
- Proscia secures $23M in Series B
funding led by Scale Venture Partners for its AI-enabled digital pathology
solutions.
- Proscia will use the funding to expand its AI application portfolio, boost commercial expansion, and advance its regulatory strategy to secure FDA approval.
Proscia, a Philadelphia-based provider of digital and
computational pathology solutions, today announced it has secured $23M in
Series B funding led by Scale
Venture
Read More
JPC Taps Proscia to Modernize World’s Largest Human Tissue Repository
What You Should Know:
- The U.S. government’s Joint Pathology Center, which
houses the world’s largest human tissue repository, today announced that
Proscia, a leading digital and AI pathology company, will provide end-to-end
modernization of JPC’s pathology operations.
- The multi-phase project will digitize the world’s
largest human pathology specimen repository in order to enhance biomedical
research for cancer and infectious diseases like COVID-19, and enable easier
data sharing with
Read More
Philips Partners With Proscia to Accelerate Open Digital Pathology Adoption
What You Should Know:
- Philips inks a collaboration with digital pathology
leader Proscia to advance an open ecosystem that helps laboratories accelerate
and scale digital pathology adoption.
- Proscia will integrate the Philips Pathology SDK to
natively utilize Philips’ iSyntax image format with its Concentriq digital
pathology platform and suite of AI modules, providing users of Philips’ digital
pathology solutions with expanded options to meet their business and
Read More
CB Insights Unveils ‘Digital Health 150’ List of Startups Transforming Healthcare
- CB Insights unveils first-ever annual ‘Digital Health 150’ list of digital health startups working to transform the healthcare industry.
- The Digital Health 150 companies span a wide spectrum of categories that involve all three key stakeholder groups for the healthcare industry — providers, payers, and patients.
- A total of 17 companies on the list are unicorns (private companies valued at $1B+). Of these, 12 companies are US-based, 3 are based in China, 1 is based in France, and 1
Read More
Proscia Raises $8M for AI-Enhanced Digital Pathology for Cancer Diagnosis
Proscia, a Philadelphia-based digital pathology platform has raised $8.3 million in Series A funding led by Boston-based Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures, and RobinHood Ventures.The startup plans to utilize the Series A funding to fuel the development and commercialization of new, clinical AI-enabled workflows targeting high-volume, high-impact cancers, the first of which will be available later this year. In
Read More
